Fact based stock research
Humana (NYSE:HUM)


Humana stock research in summary

humana.com


Humana shares have a HOLD rating. While they are safely financed, they show below average growth, and are bad value. We recommend holding Humana shares.


Latest Obermatt Ranks


Country USA
Industry Managed Health Care
Index S&P 500, D.J. US Health Care
Size class XX-Large

February 9, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()







 

Research History: Humana

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
16
23
17
17
STOCK GROWTH RANKS
50
29
43
43
STOCK SAFETY RANKS
97
18
97
97
COMBINED STOCK RANKS
50
7
57
57

Last update of Combined Rank: 9-Feb-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Humana in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2015 2016 2017 2018
PRICE VS. REVENUES (P/S)
86
86
70
70
PRICE VS. PROFITS (P/E)
34
16
39
39
PRICE VS. CAPITAL (Market-to-Book)
12
12
6
6
DIVIDEND YIELD
6
18
10
10
CONSOLIDATED RANK: VALUE
16
23
17
17

Last update of Value Rank: 9-Feb-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Humana; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
91
27
20
20
PROFIT GROWTH
66
50
34
34
STOCK RETURNS
91
26
80
80
CONSOLIDATED RANK: GROWTH
50
29
43
43

Financial reporting date of Growth Rank: 30-Sep-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Humana.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
26
32
92
92
REFINANCING
52
52
LIQUIDITY
94
7
90
90
CONSOLIDATED RANK: SAFETY
97
18
97
97

Financial reporting date of Safety Rank: 31-Jan-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Humana and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Humana from February 9, 2018.